blood
transfus
happen
hospit
stay
includ
procedur
american
medic
associ
identifi
ed
overus
fi
medic
treatmentsblood
transfus
along
cardiac
stent
ear
tube
antibiot
induct
birth
pregnant
womenand
highlight
danger
unnecessari
transfus
although
blood
transfus
believ
lifesav
assumpt
never
shown
control
clinic
trial
blood
transfus
describ
unavoid
unsaf
inher
danger
us
blood
shield
law
thu
perceiv
benefi
ts
rel
known
risk
blood
transfus
import
element
discuss
patient
inform
consent
especi
manag
anaemia
altern
blood
transfus
transfusiontransmit
infect
worri
especi
recognit
transfusionassoci
hiv
risk
tran
mission
hepa
titi
c
viru
transmiss
known
viral
agent
decreas
respons
emerg
infecti
diseas
tran
mit
blood
transfus
rapid
fi
gure
concomitantli
annual
report
transfus
fatal
us
food
drug
administr
center
biolog
evalu
research
show
decreas
allcaus
death
relat
transfus
death
attribut
transfus
report
usa
transfusionrel
acut
lung
injuri
caus
highest
percentag
report
fatal
follow
haemolyt
transfus
reaction
caus
nonabo
abo
incompat
increas
evid
suggest
patient
addit
advers
clinic
outcom
ie
increas
mor
bid
iti
mortal
associ
blood
transfus
panel
list
risk
includ
known
transmiss
pathogen
infecti
diseas
transfus
reaction
transfusionrel
acut
lung
injuri
error
blood
administr
circulatori
overload
also
potenti
yet
undefi
ned
risk
immunomodul
eg
periop
infect
tumour
progress
unknown
risk
emerg
pathogen
new
variant
creutzfeldtjakob
diseas
west
nile
viru
risk
associ
durat
blood
storag
lesion
patient
undergo
cardiac
surgeri
potenti
threat
xenotrop
murin
leukemia
virusrel
viru
xmrv
exampl
requir
exten
sive
research
determin
presenc
blood
patient
chronic
fatigu
syndrom
could
reproduc
confi
rmed
blood
donor
screen
warrant
consider
given
rise
specialti
blood
manag
support
correspond
initi
promot
app
ropriat
use
blood
blood
compon
goal
minim
use
movement
motiv
need
improv
blood
safeti
patient
outcom
preserv
blood
inventori
constrain
escal
cost
patient
blood
manag
recognis
mean
promot
avail
transfus
altern
blood
manag
cite
one
ten
key
advanc
transfus
medicin
past
year
awar
risk
cost
eff
ect
blood
inventori
led
provid
look
institutionbas
initi
patient
blood
manag
use
guidelin
restrict
use
transfus
improv
blood
use
patient
blood
manag
encompass
evidencebas
medic
surgic
approach
multidisciplinari
ie
includ
transfus
medi
cine
specialist
surgeon
anaesthesiologist
critic
care
specialist
multiprofession
ie
includ
physician
nurs
pump
technologist
pharmacist
approach
prevent
strategi
emphasis
identifi
assess
manag
anaemia
medic
surgic
patient
includ
use
pharmacolog
intervent
avoid
unnecessari
diagnost
tete
minimis
iatrogen
blood
loss
optimis
homoeostasi
use
pointofcar
test
establish
clinic
practic
guidelin
blood
transfus
recent
develop
qualityperform
indic
patient
blood
manag
healthcar
institut
accredit
organis
accompani
clinic
seri
lancet
appropri
time
look
eff
ect
patient
blood
manag
three
area
transfus
medicin
blood
utilis
altern
blood
inventori
manag
blood
suppli
depart
patholog
medicin
stanford
univers
stanford
ca
usa
ltgoodno
stanfordedu
declar
confl
ict
interest
